Swedbank Ab Royalty Pharma PLC Transaction History
Swedbank Ab
- $86.1 Billion
- Q2 2025
A detailed history of Swedbank Ab transactions in Royalty Pharma PLC stock. As of the latest transaction made, Swedbank Ab holds 12,157,470 shares of RPRX stock, worth $436 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
12,157,470
Previous 12,157,470
-0.0%
Holding current value
$436 Million
Previous $378 Million
15.74%
% of portfolio
0.51%
Previous 0.52%
Shares
13 transactions
Others Institutions Holding RPRX
# of Institutions
485Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.47 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$826 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$481 Million0.38% of portfolio
-
Viking Global Investors LP10.6MShares$379 Million1.1% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...